758 related articles for article (PubMed ID: 22340159)
21. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
Guo X; Wang L; Xia X; Wang P; Li X
Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
[TBL] [Abstract][Full Text] [Related]
22. NOX1 deficiency in apolipoprotein E-knockout mice is associated with elevated plasma lipids and enhanced atherosclerosis.
Sobey CG; Judkins CP; Rivera J; Lewis CV; Diep H; Lee HW; Kemp-Harper BK; Broughton BR; Selemidis S; Gaspari TA; Samuel CS; Drummond GR
Free Radic Res; 2015 Feb; 49(2):186-98. PubMed ID: 25496431
[TBL] [Abstract][Full Text] [Related]
23. [Effect of PMTG on atherosclerotic lesion formation and expression of ICAM-1 and VCAM-1 in ApoE-deficient mice].
Fang W; Zhang HX; Wang LY; Qin YW; Wu Y; Wang W; Liu B
Zhongguo Zhong Yao Za Zhi; 2007 Jul; 32(13):1320-3. PubMed ID: 17879736
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet.
Xu S; Little PJ; Lan T; Huang Y; Le K; Wu X; Shen X; Huang H; Cai Y; Tang F; Wang H; Liu P
Arch Biochem Biophys; 2011 Nov; 515(1-2):72-9. PubMed ID: 21889487
[TBL] [Abstract][Full Text] [Related]
25. Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats.
Li W; Tang C; Jin H; Du J
Atherosclerosis; 2011 Apr; 215(2):323-30. PubMed ID: 21300352
[TBL] [Abstract][Full Text] [Related]
26. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen sulfide inhibits macrophage-derived foam cell formation.
Zhao ZZ; Wang Z; Li GH; Wang R; Tan JM; Cao X; Suo R; Jiang ZS
Exp Biol Med (Maywood); 2011 Feb; 236(2):169-76. PubMed ID: 21321313
[TBL] [Abstract][Full Text] [Related]
28. The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
Lee IO; Kratz MT; Schirmer SH; Baumhäkel M; Böhm M
J Pharmacol Exp Ther; 2012 Nov; 343(2):253-7. PubMed ID: 22837011
[TBL] [Abstract][Full Text] [Related]
29. Splenectomy increases atherosclerotic lesions in apolipoprotein E deficient mice.
Rezende AB; Neto NN; Fernandes LR; Ribeiro AC; Alvarez-Leite JI; Teixeira HC
J Surg Res; 2011 Dec; 171(2):e231-6. PubMed ID: 21962813
[TBL] [Abstract][Full Text] [Related]
30. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
31. Increased plasma S-adenosylhomocysteine-accelerated atherosclerosis is associated with epigenetic regulation of endoplasmic reticulum stress in apoE-/- mice.
Xiao Y; Huang W; Zhang J; Peng C; Xia M; Ling W
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):60-70. PubMed ID: 25359864
[TBL] [Abstract][Full Text] [Related]
32. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.
Hoyer FF; Steinmetz M; Zimmer S; Becker A; Lütjohann D; Buchalla R; Zimmer A; Nickenig G
J Mol Cell Cardiol; 2011 Dec; 51(6):1007-14. PubMed ID: 21884703
[TBL] [Abstract][Full Text] [Related]
33. Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.
Cheung SH; Kwok WK; To KF; Lau JY
PLoS One; 2014; 9(11):e113038. PubMed ID: 25397776
[TBL] [Abstract][Full Text] [Related]
34. Effect of asymmetric dimethylarginine on atherogenesis and erythrocyte deformability in apolipoprotein E deficient mice.
Xiao HB; Yang ZC; Jia SJ; Li NS; Jiang DJ; Zhang XH; Guo R; Zhou Z; Deng HW; Li YJ
Life Sci; 2007 Jun; 81(1):1-7. PubMed ID: 17532008
[TBL] [Abstract][Full Text] [Related]
35. Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout mice.
Takase H; Hashimoto A; Okutsu R; Hirose Y; Ito H; Imaizumi T; Miyakoda G; Mori T
Arzneimittelforschung; 2007; 57(4):185-91. PubMed ID: 17515288
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanism of inhibitory effects of CD59 gene on atherosclerosis in ApoE (-/-) mice.
Li B; Xu YJ; Chu XM; Gao MH; Wang XH; Nie SM; Yang F; Lv CY
Immunol Lett; 2013; 156(1-2):68-81. PubMed ID: 24084445
[TBL] [Abstract][Full Text] [Related]
37. CSE/H
Lu X; Wang S; Feng S; Li H
BMC Nephrol; 2020 Dec; 21(1):527. PubMed ID: 33276745
[TBL] [Abstract][Full Text] [Related]
38. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
[TBL] [Abstract][Full Text] [Related]
39. Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: Role of downregulation of CD40 and MMP-9 expression.
Liu G; Wang B; Zhang J; Jiang H; Liu F
J Ethnopharmacol; 2009 Nov; 126(2):350-4. PubMed ID: 19703533
[TBL] [Abstract][Full Text] [Related]
40. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
